Leading Pharma recalls
Leading Pharma appears in 3 official U.S. recall notices indexed by RecallRadar, most recently on 2026-04-29.
Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.
Recall summary
| Recall notices | 3 |
|---|---|
| Published | 2017-11-29 to 2026-04-29 |
| By agency | FDA Drug (3) |
| By classification | Class II (2), Class III (1) |
| By status | terminated (2), ongoing (1) |
| Distribution named in notices | US |
Recalls
- Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01
FDA Drug · Class II · 2026-04-29 · Leading Pharma
Reason: CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit. - ClomiPRAMINE Hydrochloride Capsules, USP 25mg, 100-count bottles, Rx only, LEADING PHARMA, Manufactured by: Leading Pharma, LLC, Fairfield,…
FDA Drug · Class III · 2022-10-05 · Leading Pharma
Reason: Superpotent Drug: Assay value found to be 110.6% in Chlomipramine Hydrocholoride capsules - Lorazepam Tablets, USP CIV, 0.5 mg, 500-count bottle, Rx Only, Manufactured by: Leading Pharma, LLC Fairfield, NJ 07004 NDC 69315-904-05
FDA Drug · Class II · 2017-11-29 · Leading Pharma
Reason: Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepam